Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Fecal Microbiota Transplantation (FMT): PRIM-DJ2727

View source ↗

Summary

Clinical trial update on PRIM-DJ2727 fecal microbiota transplantation for recurrent Clostridioides difficile infection and multidrug-resistant Klebsiella pneumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIM-DJ2727

Snippet

Sponsor: Herbert DuPont, MD | Conditions: Recurrent Clostridium Difficile Infection, Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection | Status: AVAILABLE